← Every company
Sanofi SA SEC Filings
What Sanofi SA has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
SNY overview →Filings on file
22
since Mar 3, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jan 12, 2026 | Tender offer SC TO-T | Read ↗ |
| Jun 17, 2025 | Tender offer SC TO-T | Read ↗ |
| Mar 24, 2023 | Tender offer SC TO-T | Read ↗ |
| Aug 16, 2021 | Tender offer SC TO-T | Read ↗ |
| Aug 28, 2020 | Tender offer SC TO-T | Read ↗ |
| Dec 23, 2019 | Tender offer SC TO-T | Read ↗ |
| Apr 4, 2018 | Tender offer SC TO-T | Read ↗ |
| Feb 7, 2018 | Tender offer SC TO-T | Read ↗ |
Source: Sanofi SA's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on SNY
Company overviewEverything on SNY in one place, with the price.Insider tradingWhat SNY's own officers and directors buy and sell.Who owns itEvery manager reporting a position in SNY.Funds holding itWhich funds and ETFs hold SNY, and how big a bet.LobbyingWhat SNY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on SNY's account, and who they worked for.